MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-20-0091331
Aaarna Therapeutics Private Limited
Aaarna Therapeutics Private Limited - pharma in Nagpur, Maharashtra, India. Directors, charges & compliance details.
Revenue · FY 2025
₹44.44 Lakh
▼ 32% YoY
Net profit · FY 2025
₹52,000
Net margin 1.2%
EBITDA · FY 2025
₹72,000
EBITDA margin 1.6%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
5 yrs
Est. 2021
Directors on board
3
As per MCA filings
Brands
1
Associated brands
About Aaarna Therapeutics Private Limited
Data last updated:
Aaarna Therapeutics Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Nagpur, under CIN U24230MH2021PTC368585.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Subhash Veerbhadrappa Bawage and Shyam Munnilal Tiwari.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at House No 4122 / 841 Ahuja Nagar, Nagpur, Maharashtra, India – 440014.
As per the financials filed for FY 2025, the company reported a revenue of ₹44.44 Lakh, a decline of 32% compared to the previous year. For the same year it recorded a net profit of ₹52,000 (net margin 1.2%) and EBITDA of ₹72,000 (EBITDA margin 1.6%).
The company is associated with 1 brand: Aaarna.
Aaarna Therapeutics Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-20-0091331).
Company details
CIN U24230MH2021PTC368585
Registration Number 368585
Incorporation Date 30 September 2021
ROC Nagpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-20-0091331
Key People
Subhash Veerbhadrappa Bawage Director Shyam Munnilal Tiwari Director Pooja Munnilal Tiwari Director Recognitions & Rankings of Aaarna Therapeutics
Contact details
Aaarna Therapeutics Private Limited's registered office is in Nagpur, Maharashtra.
- Registered AddressHouse No 4122 / 841 Ahuja Nagar, Nagpur, Maharashtra, India – 440014
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Aaarna Therapeutics Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Aaarna Therapeutics operates one associated brand: AAARNA. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| mRNA-based therapeutics are developed for infectious and non-infectious human diseases. | aaarna.com |
Business activity
The main business activity of Aaarna Therapeutics is support service to organizations. In detail, this covers other support services to organizations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations |
To see the full business activity and turnover split of Aaarna Therapeutics Private Limited, buy the company report.
Financials of Aaarna Therapeutics Private Limited
FY 2025 filings availableAaarna Therapeutics Private Limited reported revenue of ₹44.44 Lakh (down 32% YoY) for FY 2025.
Revenue · FY 2025
₹44.44 Lakh ▼ 32%
Net profit · FY 2025
₹52,000 margin 1.2%
EBITDA · FY 2025
₹72,000 margin 1.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 32%
Revenue fell 32% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹72,000 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹52,000 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.6% | |||
| Net Profit Margin | 1.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Aaarna Therapeutics Private Limited, buy the company report.
Board of directors of Aaarna Therapeutics Private Limited
Aaarna Therapeutics has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Subhash Veerbhadrappa Bawage | Director | 30 Sep 2021 | 5 Years 1 Months | Current |
| Shyam Munnilal Tiwari | Director | 30 Sep 2021 | 5 Years 1 Months | Current |
| Pooja Munnilal Tiwari | Director | 26 Dec 2022 | 3 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Aaarna Therapeutics Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aaarna Therapeutics Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Aaarna Therapeutics Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Aaarna Therapeutics Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Pooja Munnilal Tiwari was appointed as Director on 26 Dec 2022.
AGM
Aaarna Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Aaarna Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Nagpur.
Appointed
Pooja Munnilal Tiwari was appointed as Director.
Appointed
Shyam Munnilal Tiwari was appointed as Director.
Appointed
Subhash Veerbhadrappa Bawage was appointed as Director.
Incorporation
30 Sep 2021
Aaarna Therapeutics Private Limited was registered on 30 Sep 2021 with Roc Nagpur & aged 5 years 1 month as per MCA records.
Frequently asked questions
Aaarna Therapeutics is an active private limited company based in Nagpur, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 September 2021 (5+ years old) and is registered under CIN U24230MH2021PTC368585.
Aaarna Therapeutics has 3 current directors:
- Subhash Veerbhadrappa Bawage - Director
- Shyam Munnilal Tiwari - Director
- Pooja Munnilal Tiwari - Director
The latest financial statements of Aaarna Therapeutics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Aaarna Therapeutics is U24230MH2021PTC368585. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aaarna Therapeutics was incorporated on 30 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Nagpur.
Pooja Munnilal Tiwari was appointed as Director on 26 Dec 2022. Shyam Munnilal Tiwari was appointed as Director on 30 Sep 2021. Subhash Veerbhadrappa Bawage was appointed as Director on 30 Sep 2021.
Yes, Aaarna Therapeutics is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-20-0091331).
The registered office of Aaarna Therapeutics is at House No 4122 841 Ahuja Nagar, Nagpur, Maharashtra, India – 440014.
Aaarna Therapeutics operates in the pharma industry, in the drug formulation and development segment.
Aaarna Therapeutics has 1 associated brand: Aaarna.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages